BeOne Medicines (BEIGF) Minority Interest (2017 - 2020)

BeOne Medicines (BEIGF) has 4 years of Minority Interest data on file, last reported at $19.6 million in Q3 2020.

• Minority Interest for Q3 2020 came in at $19.6 million, up 24.37% year-over-year; the trailing twelve-month figure through Sep 2020 was $19.6 million (up 24.37% YoY), and the FY2019 annual result was $16.2 million, up 11.8% from the prior year.
• Minority Interest advanced to $19.6 million in Q3 2020 per BEIGF's latest filing, from $10.2 million in the prior quarter.
• Over five years, Minority Interest peaked at $19.6 million in Q3 2020 and troughed at $10.2 million in Q2 2020.
• A 4-year average of $14.7 million and a median of $14.4 million in 2017 frame the typical range for Minority Interest.
• The sharpest annual moves came in 2019 and 2020: Minority Interest gained 29.07% in 2019, then slumped 41.37% in 2020.
• A 4-year view of Minority Interest shows it stood at $14.4 million in 2017, then rose by 0.16% to $14.4 million in 2018, then advanced by 11.8% to $16.2 million in 2019, then advanced by 21.36% to $19.6 million in 2020.
• Business Quant data shows BEIGF's Minority Interest at $19.6 million in Q3 2020, $10.2 million in Q2 2020, and $14.8 million in Q1 2020.